BACKGROUND: It has been proposed that artemisinin-based combination therapy (ACT) be subsidised in the private sector in order to improve affordability and access. This study in western Kenya aimed to evaluate the impact of providing subsidized artemether-lumefantrine (AL) through retail providers on the coverage of prompt, effective antimalarial treatment for febrile children aged 3-59 months. METHODS AND FINDINGS: We used a cluster-randomized, controlled design with nine control and nine i...Expand abstract
- Publication status:
- Peer review status:
- Peer reviewed
- Publisher's version
- Public Library of Science Publisher's website
- PLoS medicine Journal website
- Article: e1000437
- Publication date:
- Source identifiers:
- Local pid:
- Copyright holder:
- Kangwana et al.
- Copyright date:
- © 2011 Kangwana et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
The impact of retail-sector delivery of artemether-lumefantrine on malaria treatment of children under five in Kenya: a cluster randomized controlled trial.
If you are the owner of this record, you can report an update to it here: Report update to this record